T. Wegge

发表

Structure-based optimization of novel azepane derivatives as PKB inhibitors.

R. Huber, R. Engh, C. Breitenlechner, 2004, Journal of medicinal chemistry.

Willingness to Pay to Protect Wetlands and Reduce Wildlife Contamination from Agricultural Drainage

John B. Loomis, Barbara Kanninen, M. Hanemann, 1991 .

3D QSAR Analyses-Guided Rational Design of Novel Ligands for the (α4)2(β2)3 Nicotinic Acetylcholine Receptor

H. Gohlke, Alexander Weber, T. Wegge, 2003 .

D QSAR Analyses-Guided Rational Design of Novel Ligands for the ( r 4 ) 2 ( â 2 ) 3 Nicotinic Acetylcholine Receptor

H. Gohlke, Alexander Weber, T. Wegge, 2022 .

Comparing benefits and costs of water resource allocation policies for California's Mono basin.

W. Hanemann, J. Loomis, T. Wegge, 1996 .

An economic assessment of marine recreational fishing in southern California

W. Hanemann, I. Strand, T. Wegge, 1986 .

Design and Preclinical Development of TransCon PTH, an Investigational Sustained‐Release PTH Replacement Therapy for Hypoparathyroidism

D. Karpf, Susanne Pihl, V. Breinholt, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Synthesis and evaluation of diazine containing bioisosteres of (-)-ferruginine as ligands for nicotinic acetylcholine receptors.

M. Stubbs, T. Wegge, K. Harms, 2001, Bioorganic & medicinal chemistry.

Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.

H. Gohlke, T. Wegge, D. Gündisch, 2002, Journal of medicinal chemistry.

exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.

M. Stubbs, T. Wegge, C. Methfessel, 2001, Journal of medicinal chemistry.

A new and efficient synthetic route to enantiopure (+)-anatoxin-a from (−)-cocaine hydrochloride

T. Wegge, S. Schwarz, G. Seitz, 2000 .

Syntheses and evaluation of pyridazine and pyrimidine containing bioisosteres of (+/-)-pyrido[3.4-b]homotropane and pyrido-[3.4-b]tropane as novel nAChR ligands.

J. Siegl, T. Wegge, T. Kämpchen, 2002, Bioorganic & medicinal chemistry.

TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer

M. Tabrizi, J. Punnonen, Enping Hong, 2022, Journal for ImmunoTherapy of Cancer.

A Nested Logit Model of Recreational Fishing Demand in Alaska

W. Hanemann, R. Carson, T. Wegge, 2009, Marine Resource Economics.